Pervasis Buyout Increases Shire’s Expertise In Regenerative Medicine
This article was originally published in The Pink Sheet Daily
Executive Summary
Specialty pharma says it will position ESRD candidate Vascugel for success, just as Shire is doing with Dermagraft, acquired in last year’s buyout of Advanced BioHealing.